IOM: Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease
In 2008, the Food and Drug Administration (FDA) asked the Institute of Medicine (IOM) to conduct a study on the evaluation…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
FDA Transparency Initiative: Draft Disclosure Policies
In addition to the recently published Nation Institutes of Health (NIH) transparency Guidelines, the Food and Drug Administration…
NIH Proposed Transparency Rules
The National Institutes of Health (NIH) proposed new rules to amend its regulations on the Responsibility of Applicants…
Boston Review: Stossel Standing Up to the Unhealthy Opposition
Recently the Boston Review ran a series of six articles basically discounting almost everyone working in the field of…
AMA CEJA 2010: Financial Relationships with Industry in Continuing Medical…
Insanity: doing the same thing over and over again and expecting different results.
Albert Einstein, (attributed)
US…
Physicians Fall Behind in Crowed Work Day: CME Can Help
In addition to the severe shortage of doctors America will face over the next decade, a recent article in the New England Journal…
Richard Blumenthal’s Lyme Deception
Connecticut Attorney General Richard Blumenthal has a problem and it is just not his military record that he is exaggerating…
Boston Review: Boston Unscientific — Selling Fiction
In its May/June Issue, Boston Review takes a narrow approach at examining the important work and collaboration between industry…
Forbes: FDA Overregulation of Off Label Promotion
The Food and Drug Administration (FDA) has acknowledged for years that "good medical practice and the best interests of the…
Physician Assistants’ Emphasis on Continuing Professional Development
The Journal of the American Academy of Physician Assistants (JAAPA) recently declared that “the world of continuing medical…